DOCSLIB.ORG

Community Affairs References Committee

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Community Affairs References Committee The Senate Community Affairs References Committee Workplace exposure to toxic dust May 2006 © Commonwealth of Australia 2006 ISBN 0 642 71571 8 Senate Community Affairs References Committee Secretariat: Mr Elton Humphery (Secretary) Ms Christine McDonald (Principal Research Officer) Ms Kerrie Martain (Principal Research Officer) Ms Leonie Peake (Research Officer) Ms Ingrid Zappe (Executive Assistant) The Senate Parliament House Canberra ACT 2600 Phone: 02 6277 3515 Fax: 02 6277 5829 E-mail: [email protected] Internet: http://www.aph.gov.au/senate_ca This document was produced by the Senate Community Affairs References Committee Secretariat and printed by the Senate Printing Unit, Parliament House, Canberra. v MEMBERSHIP OF THE COMMITTEE Members Senator Claire Moore, Chair ALP, Queensland Senator Gary Humphries, Deputy Chaiman LP, Australian Capital Territory Senator Judith Adams LP, Western Australia Senator Lyn Allison AD, Victoria Senator Carol Brown ALP, Tasmania Senator Helen Polley ALP, Tasmania Participating Members Senator the Hon Eric Abetz LP, Tasmania Senator Guy Barnett LP, Tasmania Senator Andrew Bartlett AD, Queensland Senator Cory Bernardi LP, South Australia Senator Mark Bishop ALP, Western Australia Senator Bob Brown AG, Tasmania Senator George Campbell ALP, New South Wales Senator Kim Carr ALP, Victoria Senator Grant Chapman LP, South Australia Senator the Hon Richard Colbeck LP, Tasmania Senator the Hon Helen Coonan LP, New South Wales Senator Trish Crossin ALP, Northern Territory Senator Alan Eggleston LP, Western Australia Senator Chris Evans ALP, Western Australia Senator the Hon John Faulkner ALP, New South Wales Senator Alan Ferguson LP, South Australia Senator Jeannie Ferris LP, South Australia Senator Steve Fielding FFP, Victoria Senator Michael Forshaw ALP, New South Wales Senator Annette Hurley ALP, South Australia Senator Barnaby Joyce NATS, Queensland Senator Ross Lightfoot LP, Western Australia Senator Joseph Ludwig ALP, Queensland Senator Kate Lundy ALP, Australian Capital Territory Senator Julian McGauran NPA, Victoria Senator Brett Mason LP, Queensland Senator Christine Milne AG, Tasmania Senator Andrew Murray AD, Western Australia Senator Kerry Nettle AG, NSW Senator Kerry O'Brien ALP, Tasmania Senator Stephen Parry LP, Tasmania Senator Marise Payne LP, New South Wales Senator Rachel Siewert AG, Western Australia Senator Ursula Stephens ALP, New South Wales Senator Natasha Stott Despoja AD, South Australia Senator John Watson LP, Tasmania Senator Ruth Webber ALP, Western Australia Senator Penny Wong ALP, South Australia vii TABLE OF CONTENTS MEMBERSHIP OF THE COMMITTEE ................................................................. v EXECUTIVE SUMMARY.........................................................................................xi RECOMMENDATIONS ..........................................................................................xiii CHAPTER 1 INTRODUCTION..........................................................................................................1 Terms of reference..................................................................................................1 Conduct of the inquiry............................................................................................1 Background to the inquiry......................................................................................2 Impact of exposure to toxic dust .........................................................................2 Australian Safety and Compensation Council (ASCC) .........................................5 CHAPTER 2 HEALTH IMPACTS OF WORKPLACE EXPOSURE TO TOXIC DUST.................7 Crystalline silica .....................................................................................................7 Exposure to crystalline silica...............................................................................8 Silicosis............................................................................................................8 Latency.............................................................................................................9 Risks to the community .................................................................................11 Airway disease...............................................................................................12 Lung cancer....................................................................................................14 Other diseases related to respirable crystalline silica ....................................16 Beryllium..............................................................................................................17 Timber dust...........................................................................................................17 Alumina ................................................................................................................19 Textile dusts..........................................................................................................19 CHAPTER 3 THE NATURE AND EXTENT OF ILLNESS AND DISABILITY...........................21 Data sources..........................................................................................................21 Incidence of disease related to toxic dust.............................................................25 Incidence of disease related to exposure to respirable crystalline silica...........30 Silicosis..........................................................................................................31 Airway disease...............................................................................................36 Costs associated with adverse health effects .................................................37 Incidence of disease associated with beryllium ................................................37 Conclusions ..........................................................................................................38 viii CHAPTER 4 HEALTH SERVICES ..................................................................................................41 Diagnoses and medical services ...........................................................................41 Employee health surveillance...............................................................................44 Employee records ..............................................................................................48 Conclusions ..........................................................................................................49 CHAPTER 5 REGULATIONS GOVERNING WORKPLACE EXPOSURE TO TOXIC DUST...51 Occupational health and safety regulation in Australia........................................51 Workplace Chemicals Framework ....................................................................52 Prohibitions....................................................................................................53 National exposure standards..........................................................................53 National Codes of Practice and Guidance Information .................................53 State and Territory regulations .............................................................................54 Implementation of the regulatory regime.............................................................54 Timeliness..........................................................................................................54 Enforcement ......................................................................................................57 Notification of risks...........................................................................................61 Exposure standard for crystalline silica.............................................................65 Exposure standard for beryllium .......................................................................70 Conclusions ..........................................................................................................70 CHAPTER 6 COMPENSATION.......................................................................................................73 Access to compensation .......................................................................................73 Limitations in seeking legal redress .....................................................................77 Alternative models of financial support ...............................................................79 CHAPTER 7 NANOTECHNOLOGY ...............................................................................................83 Nanoscience and nanotechnology ........................................................................83 Investment in nanotechnologies ........................................................................85 Health and safety concerns...................................................................................86 Occupational health and safety issues...............................................................88 Impact on health of workers ..........................................................................89 Measurement and monitoring of nanoparticles .............................................90 Regulatory regimes........................................................................................91 Occupational health and safety research funding ..........................................92 Response to concerns.....................................................................................93
Load more

Recommended publications
  • Recorder 298.Pages
    RECORDER RecorderOfficial newsletter of the Melbourne Labour History Society (ISSN 0155-8722) Issue No. 298—July 2020 • From Sicily to St Lucia (Review), Ken Mansell, pp. 9-10 IN THIS EDITION: • Oil under Troubled Water (Review), by Michael Leach, pp. 10-11 • Extreme and Dangerous (Review), by Phillip Deery, p. 1 • The Yalta Conference (Review), by Laurence W Maher, pp. 11-12 • The Fatal Lure of Politics (Review), Verity Burgmann, p. 2 • The Boys Who Said NO!, p. 12 • Becoming John Curtin and James Scullin (Review), by Nick Dyrenfurth, pp. 3-4 • NIBS Online, p. 12 • Dorothy Day in Australia, p. 4 • Union Education History Project, by Max Ogden, p. 12 • Tribute to Jack Mundey, by Verity Burgmann, pp. 5-6 • Graham Berry, Democratic Adventurer, p. 12 • Vale Jack Mundey, by Brian Smiddy, p. 7 • Tribune Photographs Online, p. 12 • Batman By-Election, 1962, by Carolyn Allan Smart & Lyle Allan, pp. 7-8 • Melbourne Branch Contacts, p. 12 • Without Bosses (Review), by Brendan McGloin, p. 8 Extreme and Dangerous: The Curious Case of Dr Ian Macdonald Phillip Deery His case parallels that of another medical doctor, Paul Reuben James, who was dismissed by the Department of Although there are numerous memoirs of British and Repatriation in 1950 for opposing the Communist Party American communists written by their children, Dissolution Bill. James was attached to the Reserve Australian communists have attracted far fewer Officers of Command and, to the consternation of ASIO, accounts. We have Ric Throssell’s Wild Weeds and would most certainly have been mobilised for active Wildflowers: The Life and Letters of Katherine Susannah military service were World War III to eventuate, as Pritchard, Roger Milliss’ Serpent’s Tooth, Mark Aarons’ many believed.
    [Show full text]
  • A Guide to Buying P2, Or Equivalent, Respirators for Use in the Australian &
    Version 1.0 26 June 202022 June 2020 A Guide to Buying P2, or Equivalent, Respirators for use in the Australian & New Zealand Work Environment June 2020 – Version 1.0 Supported by Version 1.0 26 June 202022 June 2020 Contents About this document ............................................................................................................................... 1 Understanding the complex environment of Regulation and respiratory protection ............................... 2 National and International P2 standards ................................................................................................. 3 What do I need in place before I start using P2 or equivalent respirators? ............................................ 4 What should I look for when buying respirators? .................................................................................... 5 About the product(s) – An overview of P2 and equivalent respirators .................................................... 6 Identifying non-compliant products ....................................................................................................... 13 Contributing Organisations Australian Institute of Occupational Hygienists Australian Institute of Health & Safety New Zealand Occupational Hygiene Society Indoor Air Quality Association Australia Supported by Australian Council of Trade Unions SafeWork NSW SafeWork SA WorkSafe WA Health and Safety Association of NZ Primary Authors Kate Cole MAIOH Certified Occupational Hygienist (COH)® CF, Cole Health Jane
    [Show full text]
  • Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy
    395 Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy Ferran Morell, MD1,2 Ana Villar, MD2,3 Iñigo Ojanguren, MD2,3 Xavier Muñoz, MD2,3 María-Jesús Cruz, PhD2,3 1 Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Catalonia, Spain Address for correspondence Ferran Morell, MD, Vall d’Hebron Institut 2 Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain de Recerca (VHIR), PasseigValld’Hebron, 119-129, 08035 Barcelona, 3 Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Catalonia, Spain (e-mail: [email protected]). Barcelona, Spain Semin Respir Crit Care Med 2016;37:395–405. Abstract This review presents an update of the currently available information related to Keywords hypersensitivity pneumonitis, with a particular focus on the contribution of several ► hypersensitivity techniques in the diagnosis of this condition. The methods discussed include proper pneumonitis elaboration of a complete medical history, targeted auscultation, detection of specific ► bronchoalveolar immunoglobulin G antibodies against the most common antigens causing this disease, lavage skin tests, antigen-specific lymphocyte activation assays, bronchoalveolar lavage, and ► fi speci c inhalation cryobiopsy. Special emphasis is placed on the relevant contribution of specificinhalation challenge challenge (bronchial challenge test). Surgical lung biopsy is presented as the ultimate ► bronchial challenge recourse, to be used when the diagnosis cannot be reached through the other methods test covered.
    [Show full text]
  • RCOA Annual Report 2010-2011 Size
    refugee council of australia annual report 2010/11 www.refugeecouncil.org.au Front cover: Ayan, 16, is one of more than 60,000 people who have fled war- Acknowledgements torn south-central Somalia for Galkayo, in Somalia's Puntland region. Her goal is The Refugee Council of Australia would like to acknowledge the generous to teach the sewing skills that she has support of the following organisations and individuals for the work of the learned to other displaced girls from Council during 2010-11: poor families so they can provide for Funding support: In-kind support: their families. © UNHCR / R.Gangale • AMES Victoria • Majak Daw • Amnesty International Australia • Friends of STARTTS • Australian Cultural Orientation • Yalda Hakim Program, IOM • Carina Hoang • Australian Refugee Foundation • Host 1 Pty Ltd • City of Sydney • Gracia Ngoy • Department of Immigration and • Pitt Street Uniting Church Citizenship • Nicholas Poynder • Leichhardt Council • Timothy Seeto • McKinnon Family Foundation • Shaun Tan • Navitas • UNHCR Regional Office, Canberra • NSW AMES • University of NSW • NSW Community Relations Commission • Najeeba Wazefadost Sections • SBS • Webcity • Victorian Multicultural Commission President’s report 1 RCOA’s objectives 2 and priorities RCOA’s people 4 Refugee settlement policy 5 Asylum policy 8 International links 11 Information and 14 community education Our organisation 15 RCOA members 16 Financial report 20 President’s Report he 2010-11 financial year proved to be one of the most In the public discussion of refugee policy, in our submissions challenging and difficult for national refugee policy, in the and statements and in our private discussions with the T30-year history of the Refugee Council of Australia (RCOA).
    [Show full text]
  • Department of Pathology and Laboratory Medicine
    January 2018 CURRICULUM VITAE AGNES B. KANE PERSONAL DATA Business Address: Department of Pathology and Laboratory Medicine, Brown University, Box G-E534, Providence, Rhode Island 02912 Business Telephone Number: (401) 863-1110 Fax: (40l) 863-9008 EDUCATION B.A. Swarthmore College, Zoology 1968 M.D. Temple University School of Medicine 1974 Ph.D. Temple University School of Medicine, Experimental Pathology 1976 PROFESSIONAL APPOINTMENTS 1996-2017 Chair, Department of Pathology & Laboratory Medicine, Brown University, Providence, RI 1995-present Professor, Department of Pathology & Laboratory Medicine, Brown University, Providence, RI 1992-present Director, Training Program in Environmental Pathology, Brown University, Providence, RI 1987-95 Associate Professor, Department of Pathology & Laboratory Medicine, Brown University, Providence, RI 1982-87 Assistant Professor, Department of Pathology & Laboratory Medicine, Brown University, Providence, RI 1979-82 Staff Pathologist, Temple University Hospital, Philadelphia, PA 1977-82 Assistant Professor, Department of Pathology and Fels Research Institute, Temple University School of Medicine, Philadelphia, PA 1977-78 Resident in Anatomic Pathology, Temple University Hospital 1976-77 Postdoctoral Fellowship, National Research Service Award under Dr. Nils R. Ringertz, Medical Cell Genetics, Karolinska Institute, Stockholm, Sweden 1975-76 Resident in Anatomic Pathology, Temple University Hospital SPECIALTY BOARD CERTIFICATION 1979 Anatomic Pathology PROFESSIONAL LICENSES Pennsylvania, Rhode Island
    [Show full text]
  • Nanodata Landscape Compilation
    NanoData Landscape Compilation Environment Written by the Joint Institute for Innovation Policy, Brussels, Belgium, in co-operation with CWTS, University of Leiden, Leiden, Netherlands; Frost & Sullivan Limited, London, United Kingdom; Joanneum Research Forschungsgesellschaft mbH, Graz, Austria; the Nanotechnology Industries Association, Brussels, Belgium; Tecnalia Research and Innovation, Bilbao, Spain; and TNO, The Hague, Netherlands. August 2016 EUROPEAN COMMISSION Directorate-General for Research and Innovation Directorate Industrial Technologies Unit D.3 - Advanced Materials and Nanotechnologies E-mail: [email protected] European Commission B-1049 Brussels EUROPEAN COMMISSION NanoData Landscape Compilation Environment Written by: Jacqueline E M Allan Babette Bakker Harrie Buist Guillaume Flament Christian Hartmann Iain Jawad Eelco Kuijpers Hanna Kuittinen Ed Noyons Claire Stolwijk Xabier Uriarte Olaeta and Alfredo Yegros Additional contributions: Ashfeen Aribea Iker Barrondo Saez Robbert Fisher Milica Misojcic Luca Remotti Directorate-General for Research and Innovation 2017 Key Enabling Technologies EN EUROPE DIRECT is a service to help you find answers to your questions about the European Union Freephone number (*): 00 800 6 7 8 9 10 11 (*) The information given is free, as are most calls (though some operators, phone boxes or hotels may charge you) LEGAL NOTICE This document has been prepared for the European Commission however it reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. More information on the European Union is available on the internet (http://europa.eu). Luxembourg: Publications Office of the European Union, 2017. PDF ISBN 978-92-79-68388-6 doi: 10.2777/017097 KI-02-17-427-EN-N © European Union, 2017.
    [Show full text]
  • Workers' Compensation for Occupational Respiratory Diseases
    ORIGINAL ARTICLE http://dx.doi.org/10.3346/jkms.2014.29.S.S47 • J Korean Med Sci 2014; 29: S47-51 Workers’ Compensation for Occupational Respiratory Diseases So-young Park,1 Hyoung-Ryoul Kim,2 The respiratory system is one of the most important body systems particularly from the and Jaechul Song3 viewpoint of occupational medicine because it is the major route of occupational exposure. In 2013, there were significant changes in the specific criteria for the recognition of 1Occupational Lung Diseases Institute, Korea Workers’ Compensation & Welfare Service, Ansan; occupational diseases, which were established by the Enforcement Decree of the Industrial 2Department of Occupational and Environmental Accident Compensation Insurance Act (IACIA). In this article, the authors deal with the Medicine, College of Medicine, the Catholic former criteria, implications of the revision, and changes in the specific criteria in Korea by University of Korea, Seoul; 3Department of focusing on the 2013 amendment to the IACIA. Before the 2013 amendment to the IACIA, Occupational and Environmental Medicine, Hanyang University College of Medicine, Seoul, occupational respiratory disease was not a category because the previous criteria were Korea based on specific hazardous agents and their health effects. Workers as well as clinicians were not familiar with the agent-based criteria. To improve these criteria, a system-based Received: 20 December 2013 structure was added. Through these changes, in the current criteria, 33 types of agents Accepted: 6 April 2014 and 11 types of respiratory diseases are listed under diseases of the respiratory system. In Address for Correspondence: the current criteria, there are no concrete guidelines for evaluating work-relatedness, such Hyoung-Ryoul Kim, MD as estimating the exposure level, latent period, and detailed examination methods.
    [Show full text]
  • Silicosis: Pathogenesis and Changklan Muang Chiang Mai 50100 Thailand; Tel: 66 53 276364; Fax: 66 53 273590; E-Mail
    Central Annals of Clinical Pathology Bringing Excellence in Open Access Review Article *Corresponding author Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Silicosis: Pathogenesis and Changklan Muang Chiang Mai 50100 Thailand; Tel: 66 53 276364; Fax: 66 53 273590; E-mail: Biomarkers Submitted: 04 October 2018 Accepted: 31 October 2018 1,2 3 Attapon Cheepsattayakorn * and Ruangrong Cheepsattayakorn Published: 31 October 2018 1 10 Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand ISSN: 2373-9282 2 Department of Disease Control, Ministry of Public Health, Thailand Copyright 3 Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand © 2018 Cheepsattayakorn et al. OPEN ACCESS Abstract Ramazzini first described this disease, namely “Pneumonoultramicroscopicsilicovolcanokoniosis” Keywords and then was changed according to the types of exposed dust. No reliable figures on the silica- • Silicosis inhalation exposed individuals are officially documented. How silica particles stimulate pulmonary • Biomarkers response and the exact path physiology of silicosis are still not known and urgently require further • Pathogenesis research. Nevertheless, many researchers hypothesized that pulmonary alveolar macrophages play a major role by secreting fibroblast-stimulating factor and re-ingesting these ingested silica particles by the pulmonary alveolar macrophage with progressive magnification. Finally, ending up of the death of the pulmonary alveolar macrophages and the development of pulmonary fibrosis appear. Various mediators, such as CTGF, FBRS, FGF2/bFGF, and TNFα play a major role in the development of silica-induced pulmonary fibrosis. A hypothesis of silicosis-associated abnormal immunoglobulins has been postulated. In conclusion, novel studies on pathogenesis and biomarkers of silicosis are urgently needed for precise prevention and control of this silently threaten disease of the world.
    [Show full text]
  • Appendix Mr Bernard Collaery
    Appendix Mr Bernard Collaery Pursuant to Resolution 5(7)(b) of the Senate of 25 February 1988 Reply to statement by Senator the Hon George Brandis (4 December 2013) 1. Pursuant to Senate Privilege Resolution 5 of 25 February 1988, I request that you refer this statement to the Senate Standing Committee of Privileges, and that it be published in the Parliamentary record as a response to a statement of Senator Brandis of 4 December 2013. 2. Senator Brandis’ statement of 4 December 2013 was as follows (Hansard, pp 819–820): Yesterday, search warrants were executed at premises in Canberra by officers of the Australian Security Intelligence Organisation (ASIO) and, in the course of the execution of those warrants, documents and electronic data were taken into possession . The premises were those of Mr Bernard Collaery and a former ASIS officer. The names of ASIS officers–whether serving or past– may not be disclosed. The warrants were issued by me, at the request of ASIO, on the grounds that the documents and electronic data in question contained intelligence relating to security matters. By section 39 of the Intelligence Services Act 2001, it is a criminal offence for a current or former officer of ASIS to communicate ‘any information or matter that was prepared by or on behalf of ASIS in connection with its functions or relates to the performance by ASIS of its functions’, where the information has come into his possession by reason of his being or having been an officer of ASIS. … Last night, rather wild and injudicious claims were made by Mr Collaery and, disappointingly, by Father Frank Brennan, that the 4 purpose for which the search warrants were issued was to somehow impede or subvert the arbitration.
    [Show full text]
  • Chapter 3 CLA 180303
    Chapter 3 – Civil Liberties Australia Expanding freedom from the centre outwards As faster transport and near-instant communications began to overcome the “tyranny of distance” of Australia in the late-20th century, civil liberties in general was not moving far, or fast. In the Australian Capital Territory, a civil liberties group operated for 30 years from 4 June 1969. But as power centralised in the federal parliament, civil liberties in Canberra was down to its last person standing. The Council of Civil Liberties of the ACT formally died at the end of 2001, when the Registrar of Incorporated Associations cancelled its incorporation because the group had not lodged annual returns for three years. When the authors became aware in mid-2001 of the probable de- registration, they sought advice from then- ACT Chief Justice Terry Higgins (photo, with CLA President Dr Kristine Klugman), and were directed to Laurie O’Sullivan, a retired barrister who had run the organisation for all but the last five years of its existence. He bitterly related the tale of the ACT CCL’s death (see ACT Chapter). A nation’s capital obviously should have an active civil liberties watchdog, so the authors decided to incorporate a new body. To ensure it began life free of past political baggage (see ACT chapter), the name chosen was Civil Liberties Australia (ACT) Inc. As CLA was being born in the latter half of 2001, western life and liberty was collapsing. No-one knew when two aircraft crashed into New York’s Twin Towers (on ‘9/ll', or 11 September 2001) by how much or for how long.
    [Show full text]
  • Closing the Gap: the Impact of Nanotechnologies on the Global Divide
    NIA Report 2 Closing the Gap: The Impact of Nanotechnologies on the global Divide 26 November 2013 Cover Picture: source: Steffi Friedrichs® The NIA, Nanotechnology Industries Association, is the sector-independent, responsible voice for the industrial nanotechnologies supply chains; it proactively supports the ongoing innovation and commercialisation of nanotechnologies and promotes their safe and reliable advancement. © Nanotechnology Industries Association, 2013 Legal Notice: Neither the Nanotechnology Industries Association (NIA) nor any person acting on behalf of the NIA is responsible for the use that might be made of this publication. Nanotechnology Industries Association BRUSSELS: 101 Avenue Louise 1050 Brussels Belgium t: +32 2300 5933 e: [email protected] w: www.nanotechia.org No. d'Entreprise / Company Registration No.: 810.218.531 LISBON: Apartado 000017 EC Rebelva - Carcavelos 2776-901 Rebelva Portugal t: +351 218 200 547 e: [email protected] LONDON: Lion House Red Lion Street London, WC1R 4GB United Kingdom t: +44 7554 713 394 e: [email protected] w: www.nanotechia.co.uk Company Registration No. 6521614 i NIA Report NIA Report Closing the Gap: The Impact of Nanotechnologies on the global Divide By Guillaume Flament 1 Table of Contents Executive Summary ......................................................................................................................................... iv Glossary ............................................................................................................................................................
    [Show full text]
  • Etiology and Aggravation in Thoracic Medicine
    DePaul Law Review Volume 21 Issue 1 Fall 1971: Medico-Legal Symposium II Article 6 Etiology and Aggravation in Thoracic Medicine W. B. Buckingham Follow this and additional works at: https://via.library.depaul.edu/law-review Recommended Citation W. B. Buckingham, Etiology and Aggravation in Thoracic Medicine, 21 DePaul L. Rev. 103 (1971) Available at: https://via.library.depaul.edu/law-review/vol21/iss1/6 This Article is brought to you for free and open access by the College of Law at Via Sapientiae. It has been accepted for inclusion in DePaul Law Review by an authorized editor of Via Sapientiae. For more information, please contact [email protected]. ETIOLOGY AND AGGRAVATION IN THORACIC MEDICINE W. B. BUCKINGHAM* INTRODUCTION N THE practice of thoracic medicine, misconceptions about the etiology and/or the aggravation of thoracic diseases are common- place. These errors are frequently perpetuated by patients and occasionally by well-meaning lawyers and well-trained physicians. Superficial analysis indicates that most of these misconceptions arise from the concept of post hoc ergo propter hoc. In diseases affecting the thorax, multiple etiological factors commonly operate over pro- longed periods of time. Under such circumstances it is extremely difficult to sort out cause and effect. Thus, in light of the imperfec- tions in diagnosis, misconceptions about etiology and aggravation of disease can be appreciated. There are substantial limitations and uncertainties to any medical diagnosis. The semantic derivation of the word "diagnosis" comes through the Greek words whose meaning is "to know through" or "to understand by means of the manifestations of." A complete diagnosis in the modem sense of the term is a disease entity in which the causative mechanisms are clearly understood, and the man- ifestations readily appreciated both in clinical signs and symptoms and in laboratory findings.
    [Show full text]